Review of Industrial Organization

, Volume 39, Issue 4, pp 271–296 | Cite as

Economics at the FTC: Hospital Mergers, Authorized Generic Drugs, and Consumer Credit Markets

  • Joseph Farrell
  • David J. Balan
  • Keith Brand
  • Brett W. Wendling


Economists at the Federal Trade Commission pursue the agency’s competition and consumer protection missions. In this year’s essay, in antitrust, we discuss various aspects of our hospital merger analyses as well as the effects of authorized generic drugs on consumers and competition. In consumer protection, we describe two ongoing studies on the use of credit-based insurance scores to price homeowners insurance, and the accuracy of consumers’ credit reports that are provided by credit bureaus.


Antitrust Consumer credit Consumer protection FTC Hospital mergers Pharmaceuticals 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Balan, D. J., & Brand, K. J. (2011). Simulating hospital merger simulations. Mimeo. Retrieved from
  2. Baye M. et al (2008) Economics at the FTC: The Google-Doubleclick merger, resale price maintenance, mortgage disclosures, and credit scoring in auto insurance. Review of Industrial Organization 33(3): 211–230CrossRefGoogle Scholar
  3. Berndt E. R., Mortimer R., Bhattacharjya A., Parece A., Tuttle E. (2007) Authorized generic drugs, price competition, and consumers’ welfare. Health Affairs 26(3): 790–799CrossRefGoogle Scholar
  4. Berry S., Levinsohn J., Pakes A. (1995) Automobile prices in market equilibrium. Econometrica 63(4): 841–890CrossRefGoogle Scholar
  5. Berry S. T. (1994) Estimating discrete-choice models of product differentiation. Rand Journal of Economics 25(2): 242–262CrossRefGoogle Scholar
  6. Capps C., Dranove D. (2004) Hospital consolidation and negotiated PPO Prices. Health Affairs 23(2): 175–181CrossRefGoogle Scholar
  7. Capps C., Dranove D., Satterthwaite M. (2003) Competition and market power in option demand markets. Rand Journal of Economics 34(4): 737–763CrossRefGoogle Scholar
  8. Capps, C. S., Dranove, D., Greenstein, S., & Satterthwaite, M. (2001). The silent majority fallacy of the Elzinga-Hogarty Criteria: A critique and new approach to analyzing hospital mergers. NBER Working Paper No. 8216. Retrieved July 29, 2011, from
  9. Elzinga K. G., Swisher A. W. (2011) Limits of the Elzinga–Hogarty Test in hospital mergers: The Evanston case. International Journal of the Economics of Business 18(1): 133–146CrossRefGoogle Scholar
  10. Federal Trade Commission Report. (2007, July). Credit-based insurance scores: Impacts on consumers of automobile insurance. Retrieved from
  11. Federal Trade Commission Report. (2011). Authorized generic drugs: Short-term effects and long-term impact. Retrieved from
  12. FTC Chairman’s Annual Report. (2011). Retrieved from
  13. Goodman, M., et al. (2004, December). Quantifying the impact from authorized generics. Morgan Stanley Equity Research North America.Google Scholar
  14. Hollis A., Lang B. (2007) An assessment of the effect of authorized generics on consumer prices. Journal of Biolaw and Business 10(1): 10–18Google Scholar
  15. Mergerstat Review. (2011). Santa Monica, CA: FactSet Mergerstat, LLC.Google Scholar
  16. Romano P. S., Balan D. J. (2011) A retrospective analysis of the clinical quality effects of the acquisition of Highland Park hospital by Evanston Northwestern Healthcare. International Journal of the Economics of Business 18(1): 45–64CrossRefGoogle Scholar
  17. Scherer F. M. (1979) The welfare economics of product variety: An application to the ready-to-eat cereals industry. The Journal of Industrial Economics 28(2): 113–114CrossRefGoogle Scholar
  18. Schmalensee R. (1978) Entry deterrence in the ready-to-eat breakfast cereal industry. The Bell Journal of Economics 9(2): 305–327CrossRefGoogle Scholar
  19. Sorensen A. T. (2003) Insurer-hospital bargaining: Negotiated discounts in post-deregulation Connecticut. Journal of Industrial Economics 51(4): 469–490CrossRefGoogle Scholar
  20. Town R. (2011) The effects of US hospital consolidations on hospital quality: A comment. International Journal of the Economics of Business 18(1): 127–131CrossRefGoogle Scholar
  21. Town R., Vistnes G. (2001) Hospital competition in HMO networks. Journal of Health Economics 20(5): 733–753CrossRefGoogle Scholar
  22. Turner, M. A., Varghese, R., & Walker, P. D. (2011). US consumer credit reports: Measuring accuracy and dispute impacts. Policy and Economic Research Council (PERC).Google Scholar

Copyright information

© Springer Science+Business Media, LLC (outside the USA)  2011

Authors and Affiliations

  • Joseph Farrell
    • 1
  • David J. Balan
    • 1
  • Keith Brand
    • 1
  • Brett W. Wendling
    • 1
  1. 1.Federal Trade CommissionBureau of EconomicsWashingtonUSA

Personalised recommendations